Hepatocellular carcinoma-related genes and polypeptides, and...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007230, C435S007100, C436S006000

Reexamination Certificate

active

07871763

ABSTRACT:
Genes up-regulated in hepatocellular carcinomas and polypeptides encoded by these genes are provided. Vectors, transformants and methods for producing the recombinant polypeptides are also provided. Probes and primers of these genes and antibodies against the polypeptides are also provided. The probes, primers and antibodies can be used as reagents for detecting hepatocellular carcinomas. Methods for detecting hepatocellular carcinomas using such detection reagents are further provided. Antisense nucleotide sequences of these genes are also provided and can be used to inhibit growth of hepatocellular carcinomas.

REFERENCES:
patent: 6783961 (2004-08-01), Edwards et al.
patent: 2003/0157531 (2003-08-01), Costa et al.
patent: 2004/0235018 (2004-11-01), Nakamura et al.
patent: 2009/0035303 (2009-02-01), Nakamura et al.
patent: 1 033 401 (2000-09-01), None
patent: 1591448 (2005-11-01), None
patent: WO 99/39200 (1999-08-01), None
patent: WO9958642 (1999-11-01), None
patent: WO9966041 (1999-12-01), None
patent: WO 00/17355 (2000-03-01), None
patent: WO 00/44900 (2000-08-01), None
patent: WO-0129221 (2001-04-01), None
patent: WO-0153456 (2001-07-01), None
patent: WO 03/027143 (2003-04-01), None
patent: WO 03/027143 (2003-04-01), None
patent: WO 03/027322 (2003-04-01), None
patent: WO 03/027322 (2003-04-01), None
Sequence search result -Wong, 2010.
Sequence search result -Ruben, 2010.
Ansieau, et al.,J. Biol. Chem., 277(7):4906-4910 (2002).
Aratani, et al.,Mol. Cell. Biol., 21(14):4460-4469 (2001).
Brummelkamp, et al.,Science, 296(5567):550-553 (2002).
Cerione, et al.,Curr. Opin. Cell Biol., 8(2):216-222 (1996).
Chardin, et al.,Nature, 384(6608):481-484 (1996).
Choi, et al.,Cancer, 79(10):1879-1883 (1997).
Cukierman, et al.,Science, 270(5244):1999-2002 (1995).
Database EMBL Accession No. AK000206, Feb. 22, 2000.
Database EMBL Accession No. BG773806, May 16, 2001.
Delwel, et al.,Mol. Cell. Biol., 13(7):4291-4300 (1993).
Elbashir, et al.,Nature, 411(6836):494-498 (2001).
EMBL Accession No. AL557360, Feb. 11, 2001.
Fu, et al.,J. Virol., 67(12):6965-6972 (1993).
Gelmetti, et al.,Mol. Cell. Biol., 18(12):7185-7191 (1998).
Ghanem, et al.,Cancer, 92(12):3120-3129 (2001).
Golub, et al.,Science, 286(5439):531-537 (1999).
Gross, et al.,EMBO J., 15(8):1961-1870 (1996).
Hamamoto, et al.,Proceedings of the Am. Assoc. for Cancer Res. Annual, 43:13(#63), and English translation, (2002).
Hamamoto, et al.,94thAnnual Mtg. of the Am. Assoc. for Cancer Res., 44:54(#236), and English translation, (2003).
Hamamoto, et al.,94thAnnual Mtg. of the Am. Assoc. for Cancer Res., 44(Second Edition):47(#236), and English translation, (2003).
Hamamoto, et al.,Jpn. J. Cancer Res., 92(Supplement):117(#208), and English translation, (2001).
Hamamoto, et al.,Jpn. J. Cancer Res., 93(Supplement):78(#2032), and English translation, (2002).
Hamamoto, et al.,Jpn. J. Cancer Res., 286(#3339-OP), and English translation, (2003).
Hamamoto, et al.,Jpn Assoc. Mol. Target Ther. Cancer, 36(#SY-1), and English translation, (2002).
Hammond, et al.,Nature, 404(6775):293-296 (2000).
Hannon, et al.,Nature, 418(6894):244-251 (2002).
Herbst, et al.,Cancer, 94(5):1593-1611 (2002).
Hermouet, et al.,Proc. Natl. Acad. Sci. USA, 88(23)10455-10459 (1991).
Ito, et al.,Br. J. Cancer, 84(10):1377-1383 (2001).
Jackson, et al.,Trends Biochem. Sci., 25(10):489-495 (2000).
Kato, et al.,Jpn. J. Cancer Res., 93(Supplement):78(2033), and English translation, (2002).
Kibar, et al.,Nat. Genet., 28(3):251-255 (2001).
Lüking, et al.,Crit. Rev. Biochem. Mol. Biol., 33(4):259-296 (1998).
Lutterbach, et al.,Mol. Cell. Biol., 18(12):7176-7184 (1998).
Lyons, et al.,Science, 249(4969):655-659 (1990).
Masselink, et al.,Oncogene, 19(12):1538-1546 (2000).
Mendelsohn, et al.,Oncogene, 19(56):6550-6565 (2000).
Miyagishi, et al.,Nat. Biotechnol., 19:497-500 (2002).
Miyaki, et al.,Int. J. Cancer, 85(4):518-522 (2000).
Mochizuki, et al.,Gene, 181(1-2):39-43 (1996).
Moss, et al.,J. Biol. Chem., 270(21):12327-12330 (1995).
Nakajima, et al.,Cell, 90(6):1107-1112 (1997).
Okabe, et al.,Cancer Res., 61(5):2129-2137 (2001).
Pace, et al.,Proc. Natl. Acad. Sci. USA, 88(16):7031-7035 (1991).
Perou, et al.,Nature, 406(6797):747-752 (200).
Randazzo, et al.,Proc. Natl. Acad. Sci. USA, 97(8):4011-4016 (2000).
Sharp, P.A.,Genes Dev., 13(2):139-141 (1999).
Tanaka, et al.,Biochim. Biophys. Acta, 1536(1):1-12 (2001).
Tang, et al.,Mol. Cell. Biol., 19(5):3540-3550 (1999).
Tanner, et al.,Mol. Cell, 8(2):251-262 (2001).
von Marschall, et al.,Gut, 48(1):87-96 (2001).
Westermarck, et al.,EMBO J., 21(3):451-460 (2002).
Wolff, et al.,Development, 125(6):1149-1159 (1998).
Yagyu, et al.,Jpn. J. Cancer Res., 92(Supplement):118(209), and English translation, (2001).
Yagyu, et al.,Int. J. Oncol., 20(6):1173-1178 (2002).
Ying, et al.,Biochem. Biophys. Res. Commun., 286(2):394-400 (2001).
EMBL Accession No. AK024733, Sep. 29, 2000.
Chiosis et al., BioOrg. Med. Chem., 10(11):3555-3564 (2002).
Fantin et al., Cancer Cell., 2(1):29-42 (2002).
Firestein et al., Mol. Cell. Biol., 20(7):4900-4909 (2000).
Kennell et al., Pro. Nucleic Asid Res. Mol. Biol., 11:259-301 (1971).
Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction , 492-495 (1994).
Rozovskaia et al., Oncogene., 19(3):351-357 (2000).
Rudinger et al., Peptide Hormones: University Park Press, 1-7 (1976).
Shiff et al, J. Clin. Invest., 96(1):491-503 (1995).
Katoh et al., “Molecular Cloning and Characterization of Strabismus 2 (STB2)”, Intl. J. Oncol., 20(5):993-998 (2002).
Katoh et al., “Strabismus (STB)/Vang-like (VANGL) Gene Family (Review)”, Int. J. Mol. Med., 10(1):11-15 (2002).
Gen Bank Accession No. AB057596, May 14, 2002.
Accession No. aac02474, Feb. 11, 1998.
Accession No. AAA08583, N-Genseq-200701 Database, Jul. 19, 2000.
Accession No. BE747972, EST Database, Sep. 15, 2000.
Carninci et al., “Normalization and Subtraction of Cap-Trapper-Selected cDNAs to Prepare Full-Length cDNA Libraries for Rapid Discovery of New Genes”,Genome Res., 10:1617-1630 (2000).
Eck et al., “Gene-Based Therapy”, inThe Pharmacological Basis of Therapeutics, Chapter 5, pp. 77-101, Goodman and Gilman Eds., McGraw-Hill, New York (1996).
Orkin et al., “Report and Recommendation of the Panel to Assess the NIH Investment in Research in Gene Therapy”, pp. 1-41 (1995).
US-10-490-605A-4, Uniport 7.2 Database (2006).
Verma et al., “Gene therapy—promises, problems and prospects”,Nature, 389:239-242 (1997).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hepatocellular carcinoma-related genes and polypeptides, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatocellular carcinoma-related genes and polypeptides, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatocellular carcinoma-related genes and polypeptides, and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2625474

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.